2021-01-05,Cyclo Therapeutics Announces Positive Efficacy Data from Extension Protocol with TrappsolÂ® Cyclo in Patients with Niemann-Pick Disease Type C
2020-12-22,Cyclo Therapeutics Announces Closing of Underwriters Option to Purchase Additional Shares of Common Stock in Connection with its Underwritten Public Offering
2020-12-12,What Can We Learn About Cyclo Therapeutics' (NASDAQ:CYTH) CEO Compensation?
